These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18091321)

  • 61. Hesa-A Down-Regulates erb/b2 Oncogene Expression and Improves Outcome of Oral Carcinoma in a Rat Model.
    Abbasi MM; Mehdipour M; Monfaredan A; Jahanban-Esfahlan R
    Asian Pac J Cancer Prev; 2015; 16(16):6947-51. PubMed ID: 26514473
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Steroid hormone receptors, MIB-1, p53, and c-erb-B2 expression on breast cancer: Comparison of immunohistochemistry on cell block and fine needle aspiration and tissue sample, in northwest Iran.
    Mardanpour K; Rahbar M
    Caspian J Intern Med; 2012; 3(4):523-9. PubMed ID: 24009928
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunohistochemical Analysis of p53, Ki-67, CD44, HER-2/neu Expression Patterns in Gastric Cancer, and Their Association with One Year Survival in North-West of Iran.
    Sanaat Z; Halimi M; Ghojezadeh M; Pirovi AH; Gharamaleki JV; Ziae AE; Kermani IA
    Int J Hematol Oncol Stem Cell Res; 2013; 7(3):15-20. PubMed ID: 24505530
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical value of cyclooxygenase-2 expression in human breast carcinoma.
    Ahn JH; Kim SB; Ahn SH; Gong GY; Ahn MJ; Kang YK; Lee JS; Kim WK
    Cancer Res Treat; 2004 Jun; 36(3):192-8. PubMed ID: 20396544
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of the molecular genetics of c-erb-B2 and p53 expression in stomach cancer in Britain and Japan.
    McCulloch PG; Ochiai A; O'Dowd GM; Nash JR; Sasako M; Hirohashi S
    Cancer; 1995 Feb; 75(4):920-5. PubMed ID: 7842412
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries.
    Corbo V; Beghelli S; Bersani S; Antonello D; Talamini G; Brunelli M; Capelli P; Falconi M; Scarpa A
    Ann Oncol; 2012 Jan; 23(1):127-134. PubMed ID: 21447618
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
    O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
    Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Expression of p53, Ki-67, bcl-2, c-erb-2, estrogen, and progesterone receptors in endometrial cancer].
    Pilka R; Mícková I; Lubuský M; Dusková M; Rícánková M; Kudela M
    Ceska Gynekol; 2008 Jul; 73(4):222-7. PubMed ID: 18711961
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A
    Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Chikhlikar PR; Ghosh N; Trivedi TI
    Ann Surg Oncol; 2000 May; 7(4):305-11. PubMed ID: 10819372
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pancreatic endocrine tumors-c-erb B2 (Her-2/neu), bcl-2, and p-53 immunohistochemical testing and their value in assessing prognosis.
    Proca DM; Frankel WL
    Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):44-7. PubMed ID: 18091321
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.